OMB control number
Financial Disclosure by Clinical Investigators
OMB 0910-0396 · HHS/FDA.
OMB 0910-0396
The collection require sponsors of any drug, biologic or device marketing application to certify to the absence of clinical investigators and/or disclose those financial interests as required, when covered clinical studies are submitted to FDA in support of product marketing.
The latest form for Financial Disclosure by Clinical Investigators expires 2028-07-31 and can be found here.
Latest Forms, Documents, and Supporting Material
Document Name |
|---|
Form |
Form |
Supporting Statement A |
All Historical Document Collections
| Extension without change of a currently approved collection | 2025-05-05 | ||
|
Approved without change |
Extension without change of a currently approved collection | 2022-03-31 | |
|
Approved without change |
Extension without change of a currently approved collection | 2019-03-14 | |
|
Approved with change |
Extension without change of a currently approved collection | 2015-11-06 | |
|
Approved with change |
Extension without change of a currently approved collection | 2012-07-27 | |
|
Approved with change |
Extension without change of a currently approved collection | 2009-04-28 | |
|
Approved without change |
Extension without change of a currently approved collection | 2006-02-16 | |
|
Approved without change |
Reinstatement with change of a previously approved collection | 2003-01-02 | |
|
Withdrawn |
Reinstatement without change of a previously approved collection | 2002-07-08 | |
|
Approved without change |
New collection (Request for a new OMB Control Number) | 1999-01-15 |
OMB Details
Certification--54.4(a)(1) and (a)(2)--Form FDA 3454
Federal Enterprise Architecture: Health - Consumer Health and Safety
| Form 3454 | CERTIFICATION: FINANCIAL INTERESTS AND ARRANGEMENTS OF CLINICAL INVESTIGATORS | Fillable Fileable | Form |
Review document collections for all forms, instructions, and supporting documents - including paper/printable forms.